Dr. Marc Russo discusses his research on ultra-low frequency SCS and its potential to treat nociceptive ...
Carsten Schroeder, president and CEO of Terumo Neuro, discusses the company’s plans to capture share and...
Q’Apel Medical CEO Jodie Fam discusses the company, strategies for growth and Q’Apel’s approach to innov...
SmartTRAK reports on the latest research and innovation in neurointervention from ESMINT 2024. The Europ...
SmartTRAK reports the latest research and innovation in interventional pain management from ASPN 2024. I...
Amaza Reitmeier, Medtronic’s VP and GM of Brain Modulation, discusses the company’s recent FDA approvals...
Ariel Sutton, EVP and GM of Imperative Care’s Stroke business, discusses the Imperative Trial, the compa...
ASPN Chairman Tim Deer, MD, discusses the research and innovation at ASPN 2024 and the society’s collabo...
INS President Dr. Marc Russo and INS President-Elect Dr. Konstantin Slavin discuss the current “state of...
Medtronic’s David Carr, VP & GM, Pain Interventions, discusses Inceptiv closed-loop SCS in an interv...
Login